Results 151 to 160 of about 125,964 (294)

EU Joint Clinical Assessment: A Framework for Optimising Use with Cost-Effectiveness Decision-Making

Journal of Market Access & Health Policy
The introduction of the European Union (EU) Joint Clinical Assessment (JCA) under Regulation (EU) 2021/2282 marks a transformative step in harmonizing health technology assessments (HTAs) across EU member states. This article explores the implications of
Adam Johns, André Andrade, Sukhvinder Johal, James Ryan   +3 more
doaj   +1 more source

Why is it so difficult to integrate ethics in Health Technology Assessment (HTA)? The epistemological viewpoint [PDF]

, 2016
Ethics has been identified as a key element in Health Technology Assessment (HTA) since its conception. However, ethical issues are still not frequently addressed explicitly in HTA. Several valuable reasons have been identified.
Brereton, Louise, Gerhardus, Ansgar, Hofmann, Bjorn, Lysdahl, Kristin Bakke, Mozygemba,, Kati, Oortwijn, Wija, Refolo, Pietro, Sacchini,, Dario, Spagnolo, A.G., Tummers,, Marcia, van der Wilt, Gert-Jan, Wahlster, Philip   +11 more
core   +1 more source

A Cost Consequence Analysis of Seven Diagnostic Strategies for Ovarian Cancer: A Model‐Based Economic Evaluation

BJOG: An International Journal of Obstetrics &Gynaecology, Volume 133, Issue 4, Page 680-689, March 2026.
ABSTRACT Objective To assess the costs and consequences of seven diagnostic strategies for ovarian cancer in pre‐ and post‐menopausal women with symptoms in secondary care. Design Economic evaluation alongside a prospective single‐arm diagnostic accuracy study.
Samuel J. Perry, Donal Griffin, Eleanor V. Williams, Tracy E. Roberts, Fong Lien Kwong, Sarah Williams, Jon Deeks, Katie Scandrett, Ridhi Agarwal, Sudha S. Sundar, Mark Monahan   +10 more
wiley   +1 more source

PCASE3 HTA PROCEDURES IN DRUG REIMBURSEMENT PROCESS IN POLAND. EVOLUTION OF RECOGNITION THE ROLE OF AGENCY OF HEALTH TECHNOLOGY ASSESSMENT (AHTAPOL) BY POLICY MAKERS

, 2009
ZJ Krol, W Matusewicz, A Musialowicz
openalex   +1 more source

A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer’s disease and agitated behaviours: the HTA-SYMBAD trial

, 2023
Sube Banerjee, Nicolas Farina, Catherine Henderson, Juliet High, Susan Stirling, Lee Shepstone, Julia Fountain, Clive Ballard, Peter Bentham, Alistair Burns, Chris Fox, Paul T. Francis, Robert Howard, Martín Knapp, Iracema Leroi, Gill Livingston, Ramin Nilforooshan, Shirley Nurock, John T. O’Brien, Annabel Price, Alan Thomas, Ann Marie Swart, Tanya Telling, Naji Tabet   +23 more
openalex   +2 more sources

Once‐weekly insulin icodec versus once‐daily insulin degludec for type 2 diabetes in China: A cost‐utility and budget impact analysis

Diabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 2393-2402, March 2026.
Abstract Aims Insulin icodec, the first once‐weekly basal insulin analogue, was approved in China in 2024. Although it has demonstrated robust clinical efficacy, its budget impact remains unknown, and the long‐term cost‐utility within the reimbursement context needs further estimates.
Xichen Tong, Yawen Zhang, Lei Zhang, Luying Zhang   +3 more
wiley   +1 more source

„HTA und Impact“: Erfahrungen des Ludwig Boltzmann Instituts für HTA/Österreich

, 2011
[for full text, please go to the a.m. URL]
openaire   +2 more sources

Long‐term follow‐up of a randomised controlled trial of a brief home‐based parenting intervention to reduce behavioural problems in young children

Journal of Child Psychology and Psychiatry, Volume 67, Issue 3, Page 321-332, March 2026.
Background Behaviour problems are common in childhood and are associated with higher rates of mental health problems, educational and relationship difficulties throughout life. This study assessed whether a Video‐feedback Intervention to promote Positive Parenting and Sensitive Discipline (VIPP‐SD) has sustained benefit 6 years after delivery.
Paul Ramchandani, Jack Elkes, Victoria Cornelius, Sarah Byford, Laura Oxley, Daphne Babalis, Beth Barker, Erin Bibby, Brittney Chere, Poushali Ganguli, Sam Griffith, Zaheema Iqbal, Aiman Kamarudin, Katie Lui, Stephen Scott, Emma Tassie, Essi Viding, Christine O'Farrelly   +17 more
wiley   +1 more source

HTA58 HTA Assessment of Single-Arm Trials: Comparison between the HAS and SMC [PDF]

I Reguei, W Belgaied, M.S. Bagga, Z Hammami, Farah Moalla, Mondher Toumi   +5 more
openalex   +1 more source

Editorial: Where to from here: Advancing patient and public involvement in health technology assessment (HTA) following the COVID-19 pandemic [PDF]

, 2023
Janet Wale, Marie‐Pascale Pomey
openalex   +1 more source